Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
 |
Results for 'Stakeholder Insight: Anxiety Disorders' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Stakeholder Insight: Major Depressive Disorder Duloxetine - Fulfilling An Unmet Need? |
March 2006 | £8695 | 100 % |
|
Myelodysplastic Syndromes - First Approvals Spur Some Interest In A Niche Market Stakeholder Opinions |
December 2007 | £2005 | 23.8 % |
|
Stakeholder Opinions: Female Sexual Dysfunction Results from Datamonitor's 2005 physician survey |
June 2007 | £2005 | 21.35 % |
|
Stakeholder Insight: Metabolic Syndrome Multiple definitions complicate treatment |
April 2006 | £8690 | 15.4 % |
|
Stakeholder Opinions: Melanoma Lucrative commercial opportunities persist |
December 2006 | £2005 | 8.75 % |
